Cancer Clinical Trials | Maryland | Adventist HealthCare

Clinical Trials

Browse cancer clinical trials at Adventist HealthCare.

What’s a Clinical Trial?

A clinical trial is a research study that tests a new medical device, medication or other therapy before it’s widely available. The study is done to see if the treatment works safely. The results of the study help researchers learn better ways to prevent, detect or treat cancer.

Should I Participate in a Clinical Trial?

When you take part in a clinical trial, your health may improve from the treatment. But it may not, and you may have side effects. Talk to your doctor about the potential risks and benefits.

Expert Researchers

At Adventist HealthCare, your clinical trial will be led by a team of specialists made up of doctors, clinical research nurses, research associates and assistants who do more than 65 cancer studies each year.

Search Cancer Clinical Trials

Showing 1-10 of 38

Sorted By:

  • ARCTIC

    Randomised, open label, multi-centre study assessing the efficacy and safety of MEDI4736 versus Standard of Care in NSCLC patients with PD-L1 positive tumours.

  • ARROW

    Study compares once-weekly carfilzomib dosing in combination with dexamethasone to twice-weekly carfilzomib dosing in combination with dexamethasone.

  • BAX69391401

    Study evaluates the safety and tolerability of BAX69 in combination with 5-fluorouracil (5-FU)/leucovorin (LV) or panitumumab to determine the recommended phase II dose (RP2D) of each combination.

  • Ceritinib with Low-fat Meal

    Study to assess the systemic exposure, effiacy, and safety of 450 mg ceritinib taken with a low-fat meal and 600 mg ceritinib taken with a low-fat meal.

  • Doxorubicin Hydrochloride/Cyclophosphamide

    Study of how doxorubicin hydrochloride and cyclophosphamide followed by paclitaxel work in treating patients with triple negative breast cancer.

  • Elevate CLL R/R

    Study to evaluate PFS endpoint for acalabrutinib vs ibrutinib in previously treated chronic lymphocytic leukemia.

  • ERA 223

    Study to determine if the addition of radium-223 dichloride to standard treatment is able to prolong life and to delay events specific for prostate cancer.

  • GAMMA-1

    Study to compare the efficacy of andecaliximab (formerly GS-5745) versus placebo as measured by overall survival.

  • IMbassador250

    Study evaluates the safety and efficacy of atezolizumab in combination with enzalutamide compared with enzalutamide alone in participants with mCRPC.

  • IMpassion130

    Study evaluates the efficacy, safety, and pharmacokinetics of atezolizumab administered with nab-paclitaxel compared with placebo.

Page InfoPage
Page of 4, showing trials 1-10 of 38

Talk to a Cancer Navigator

Request a free consultation today to learn about our services.

Request a Consult

Set Your Location

Setting your location helps us to show you nearby providers and locations based on your healthcare needs.